These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 22418890)

  • 21. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.
    Karra E; Yousseif A; Batterham RL
    Trends Endocrinol Metab; 2010 Jun; 21(6):337-44. PubMed ID: 20133150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bariatric surgery and the gut-brain communication--the state of the art three years later.
    Diniz Mde F; Azeredo Passos VM; Diniz MT
    Nutrition; 2010 Oct; 26(10):925-31. PubMed ID: 20392599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of nonalcoholic steatohepatitis: an evidence-based approach.
    Mahady SE; George J
    Clin Liver Dis; 2012 Aug; 16(3):631-45. PubMed ID: 22824485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular benefits of bariatric surgery in morbidly obese patients.
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Obes Rev; 2011 Jul; 12(7):515-24. PubMed ID: 21348922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese.
    Shaffer EA
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S44-50. PubMed ID: 16540767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.
    De Ridder RJ; Schoon EJ; Smulders JF; van Hout GC; Stockbrügger RW; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():195-201. PubMed ID: 18081662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic histology in obese patients undergoing bariatric surgery.
    Machado M; Marques-Vidal P; Cortez-Pinto H
    J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery.
    de Andrade AR; Cotrim HP; Alves E; Soares D; Rocha R; Almeida A; Almeida CG; de Freitas LA
    Ann Hepatol; 2008; 7(4):364-8. PubMed ID: 19034237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G; Gambino R; Cassader M
    Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver disease in obese patients].
    Giostra E; Huber O; Morel P; Hadengue A
    Rev Med Suisse; 2007 Sep; 3(123):1939-41. PubMed ID: 17918488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in adipocytokines and cGMP homeostasis in morbid obesity patients reverse after bariatric surgery.
    Felipo V; Urios A; García-Torres ML; El Mlili N; del Olmo JA; Civera M; Ortega J; Ferrandez A; Martínez-Valls J; Cassinello N; Montoliu C
    Obesity (Silver Spring); 2013 Feb; 21(2):229-37. PubMed ID: 23404955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.
    Dixon JB; Bhathal PS; Hughes NR; O'Brien PE
    Hepatology; 2004 Jun; 39(6):1647-54. PubMed ID: 15185306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of bariatric surgery on the non-alcoholic liver steatosis. A histological evaluation].
    Ferrer Márquez M; Carvia Pousaillè C; Velasco Albendea J; Rico Morales Mdel M; Casado Martín M; Belda Lozano R; Ferrer Ayza M
    Cir Esp; 2009 Aug; 86(2):94-100. PubMed ID: 19560754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
    Mishra P; Nugent C; Afendy A; Bai C; Bhatia P; Afendy M; Fang Y; Elariny H; Goodman Z; Younossi ZM
    Liver Int; 2008 Sep; 28(8):1080-6. PubMed ID: 18647236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?
    Hafeez S; Ahmed MH
    J Obes; 2013; 2013():839275. PubMed ID: 23431426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.